Back
Surgery Partners Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
42
SGRY
Surgery Partners
Last Price:
$22.62
Seasonality Move:
-2.43%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SGRY is experiencing buying pressure, which is a positive indicator for future bullish movement.
Surgery Partners Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 22.24 | Buy |
20-day SMA: | 21.65 | Buy |
50-day SMA: | 22.52 | Buy |
200-day SMA: | 24.17 | Sell |
8-day EMA: | 18.45 | Buy |
20-day EMA: | 11.22 | Buy |
50-day EMA: | 5.44 | Buy |
200-day EMA: | 1.51 | Buy |
Surgery Partners Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.08 | Buy |
Relative Strength Index (14 RSI): | 54.39 | Buy |
Chaikin Money Flow: | 1230323 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.91 - 22.97) | Buy |
Bollinger Bands (100): | (21.46 - 24.12) | Sell |
Surgery Partners Technical Analysis
Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Surgery Partners Stock
Is Surgery Partners Stock a Buy?
-
Surgery Partners share price is 22.64 while SGRY 8-day simple moving average is 22.24, which is a Buy signal.
-
The stock price of SGRY is 22.64 while Surgery Partners 20-day SMA is 21.65, which makes it a Buy.
-
Surgery Partners 50-day simple moving average is 22.52 while SGRY share price is 22.64, making it a Buy technically.
-
SGRY stock price is 22.64 and Surgery Partners 200-day simple moving average is 24.17, creating a Sell signal.
SGRY Technical Analysis vs Fundamental Analysis
Sell
42
Surgery Partners (SGRY)
is a Sell
Is Surgery Partners a Buy or a Sell?
-
Surgery Partners stock is rated a SellThe current Surgery Partners [SGRY] share price is $22.64. The Score for SGRY is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
Surgery Partners Stock Info
Market Cap:
2.9B
Price in USD:
22.64
Share Volume:
1.9M
Surgery Partners 52-Week Range
52-Week High:
33.97
52-Week Low:
18.87
Sell
42
Surgery Partners (SGRY)
is a Sell
Surgery Partners Share Price Forecast
-
What is the Surgery Partners stock price today?The Surgery Partners stock price is 22.64 USD today.
-
Will SGRY stock go up or go down?Surgery Partners> share price is forecast to RISE/FALL based on technical indicators
-
Is Surgery Partners overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Surgery Partners is overvalued.
Is Surgery Partners Stock a Buy?
-
Surgery Partners share price is 22.64 while SGRY 8-day exponential moving average is 18.45, which is a Buy signal.
-
The stock price of SGRY is 22.64 while Surgery Partners 20-day EMA is 11.22, which makes it a Buy.
-
Surgery Partners 50-day exponential moving average is 5.44 while SGRY share price is 22.64, making it a Buy technically.
-
SGRY stock price is 22.64 and Surgery Partners 200-day simple moving average is 1.51, creating a Buy signal.
Fundamental Analysis of Surgery Partners
Is Surgery Partners a good investment?
-
Analysts estimate an earnings increase this quarter of $0.05 per share, an increase next quarter of $0.01 per share, an increase this year of $0.00 per share, and an increase next year of $0.23 per share.
Technical Analysis of Surgery Partners
Should I short Surgery Partners stock?
-
SGRY Moving Average Covergence Divergence (MACD) indicator is 6.08, suggesting Surgery Partners is a Buy
-
Surgery Partners Relative Strength Index (RSI) is 54.39, which suggest Surgery Partners is overbought
-
The Bollinger Bands (25) for Surgery Partners is (20.91 - 22.97), which suggest Surgery Partners is a Sell
-
The Bollinger Bands (100) for Surgery Partners is (21.46 - 24.12), which suggest Surgery Partners is a Sell
* Surgery Partners stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.